Impact of preoperative brachytherapy followed by radical hysterectomy in stage IB2 (FIGO 2018) cervical cancer: An analysis of SENTICOL I-II trials von Kissel, M., Balaya, V., Guani, B., Magaud, L., Mathevet, P., Lécuru, F., Uzan, C., Morice, P., Stoeckle, E., Fourchotte, V., Querleu, D., Baron, M., Ott, B., Darai, E., Leveque, J., Lanvin, D., Pomel, C., Marret, H., Leblanc, E., Houvenaeghel, G., Rouanet, P., Descamps, P., Mage, G., Graesslin, O., Baldauf, J.J., Classe, J.M., Raudrant, D., Conri, V., Douvier, S., Barranger, E., Leguevaque, P., Fouché, Y., Boulanger, L., Magaud, L., Schott, A.M., Bouttitie, F.

Volltext

Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study von Tantari, Matteo, Bogliolo, Stefano, Morotti, Matteo, Balaya, Vincent, Bouttitie, Florent, Buenerd, Annie, Magaud, Laurent, Lecuru, Fabrice, Guani, Benedetta, Mathevet, Patrice, On Behalf Of The Senticol Group

Volltext